DOI: https://dx.doi.org/10.18565/epidem.2021.11.1.25-9
Stashko T.V., Meskina E.R., Shilkina I.M., Osipov A.A.
1) M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia; 2) Domodedovo Central Town Hospital, Domodedovo, Moscow Region, Russia
1. Wang Y., Wang Y., Chen Y., Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J. Med. Virol. 2020; 92(6): 568–76. doi: 10.1002/jmv.25748 2. Miller I.F., Becker A.D., Grenfell B.T., Metcalf C.J.E. Disease and healthcare burden of COVID-19 in the United States. Nat. Med. 2020. doi: 10.1038/s41591-020-0952-у 3. Geographic distribution of COVID-19. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases 4. Nussbaumer-Streit B., Mayr V., Dobrescu A.I., Chapman A., Persad E., Klerings I. et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst. Rev. 2020; 4(4): CD013574. doi: 10.1002/14651858.CD013574 5. Islam N., Sharp S.J., Chowell G., Shabnam S., Kawachi I., Lacey B. et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ 2020; 370: m2743. doi: 10.1136/bmj.m2743 6. Choi J.Y. COVID-19 in South Korea. Postgrad. Med. J. 2020; 96(1137): 399–402. doi:10.1136/postgradmedj-2020-137738 7. Grant M.C., Geoghegan L., Arbyn M., Mohammed Z., McGuinness L., Clarke EL et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries. PLoS ONE 2020; 15(6): e0234765. https://doi.org/10.1371/journal.pone. 0234765 8. Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020; (10): 1001. doi:10.1001/jamacardio.2020.1286 9. Liang W., Liang H., Ou L., Chen B., Chen A., Li C., et al. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern. Med. 2020: e202033. doi: 10.1001/jamainternmed.2020.2033
Tatiana V. Stashko, Junior Researcher, Unit for Childhood Infections, Department of Therapy, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia; stashko.tatyana@mail.ru; https://orcid.org/0000-0001-9654-9863
Elena R. Meskina, MD; Head, Unit for Childhood Infections, Department of Therapy, M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia; meskinaelena@rambler.ru; https://orcid.org/0000-0002-1960-6868
Irina M. Shilkina, Head, Unit for Infections, Domodedovo Central Town Hospital; Principal Out-of-Staff Infectiologist, Ministry of Health of the Moscow Region, Domodedovo, Moscow Region, Russia; shim-48@mail.ru
Andrey A. Osipov, Chief Doctor, Domodedovo Central Town Hospital; Domodedovo, Moscow Region, Russia; dcgb1@mail.ru